August 12, 2022
The University of Cincinnati's Alberto Espay, MD, joined WVXU's Cincinnati Edition to discuss recent allegations that a key 2006 Alzheimer's study from the University of Minnesota may have been fabricated.
August 30, 2022
With hybrid work here to stay, employers need to develop more creative and productive solutions for their employees to work both from home and in the office, research from a University of Cincinnati dean found.
September 16, 2022
WLWT and Yahoo News highlighted work being done by University of Cincinnati Cancer Center researchers to advance cancer care through new immunotherapy and cellular therapy treatments.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
June 15, 2022
The University of Cincinnati's Paul Crosby, MD, was a guest on Local 12's What's Happening in Health program to discuss the ongoing mental health crisis and the Lindner Center of HOPE's new campaign to expand services.
June 13, 2022
University of Cincinnati professors and radiologists Ann Brown and Mary Mahoney joined patient advocate Michele Young and state legislators to celebrate the passage of House Bill 371, a bill that will require insurance companies to cover additional breast cancer screenings.
June 13, 2022
WCPO featured the University of Cincinnati's Jonathan Forbes, MD, in a story about his recent trip to Ukraine where he helped create an ICU train to move Ukrainian soldiers from the frontlines.
June 16, 2022
The University of Cincinnati's Michael Privitera was featured in a MSN article commenting on a recent study that found the cost of brand-name epilepsy drugs has nearly tripled in eight years.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
June 10, 2022
Healio highlighted clinical trial data presented by University of Cincinnati professor and Cincinnati Children's Hospital Medical Center oncologist Robin Norris on a new combination treatment for young patients with advanced-stage Hodgkin lymphoma.